Lenalidomide Plus RT Linked to Longer PFS in Plasmacytoma
Summary
In a small retrospective study, adding lenalidomide-dexamethasone to RT was associated with higher 10-year PFS in solitary plasmacytoma. However, multiple myeloma-free survival did not differ significantly between groups. Medscape Medical News
Description from Medscape.
Who is covering this
-
Lenalidomide Plus RT Linked to Longer PFS in Plasmacytoma
In a small retrospective study, adding lenalidomide-dexamethasone to RT was associated with higher 10-year PFS in solitary plasmacytoma. However, multiple myeloma-free survival did not differ significantly between groups. Medscape Medical News
Comments
Comments need JavaScript.